Table 2.
Demographic data and co-morbidities in both study groups.
| Item | Group I (n = 50) | Group II (n = 50) | p-value |
|---|---|---|---|
| 1. Age (years), mean ± SD | 35.40 ± 10.62 | 36.58 ± 11.05 | p = 0.588 |
| 2. Sex | |||
| Male | 16 (32.0%) | 18 (36.0%) | p = 0.47 |
| Female | 34 (68.0%) | 32 (64.0%) | |
| 3. Weight (kg), mean ± SD | 141.00 ± 25.85 | 134.80 ± 22.06 | p = 0.200 |
| 4. Height (cm), mean ± SD | 168.89 ± 4.83 | 170.40 ± 5.19 | p = 0.119 |
| 5. BMI (kg/m2), mean ± SD | 49.35 ± 8.00 | 47.29 ± 6.27 | p = 0.261 |
| 6. Diabetes | 21 (42.0%) | 20 (40.0%) | p = 0.50 |
| 7. Asthma | 3 (6.0%) | 5 (10.0%) | p = 0.357 |
| 8. Hypertension | 24 (48.0%) | 26 (52.0%) | p = 0.421 |
| 9. OSA | 4 (8.0%) | 5 (10.0%) | p = 0.500 |
SD: standard deviation; OSA: obstructive sleep apnoea; BMI: body mass index; PCA: patient-controlled analgesia.
Group I: intrathecal morphine group; Group II: PCA group.